Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Grapevine
AddedFeb 16, 2024
UpdatedJun 18, 2026
Grapevine

Grapevine

Pre-Seed

NYC-based Grapevine offers a unified procurement solution, streamlining medical supply sourcing and purchasing, promising up to 60% savings.

HQ
New York City, NY, US
Founded
2022
Overview
Compare
Fundraising
Employees
Website

Founded in New York City, Grapevine is dedicated to revolutionizing the procurement process for medical supplies. The company's core mission is to streamline sourcing and purchasing, enabling healthcare providers to save time and reduce costs. Grapevine offers a unified procurement solution that integrates existing suppliers while providing access to a network of over 250 vendors across the United States. By leveraging intelligence-based shopping, Grapevine ensures that users can compare products and secure the best prices, promising up to 60% savings.

Grapevine has garnered attention for its innovative approach to procurement, attracting notable investors and industry experts. The platform's ability to consolidate supplier networks and provide significant cost reductions has made a substantial impact on the healthcare supply chain. By simplifying the procurement process and enhancing vendor access, Grapevine empowers healthcare providers to operate more efficiently and economically.

Grapevine - Similar Companies

InvoCure logo

InvoCure

invocure.com

DocShop Pro logo

DocShop Pro

docshoppro.com

Ravacan logo

Ravacan

ravacan.com

Stimulus logo

Stimulus

getstimulus.io

bttn logo

bttn

bttnusa.com

Vendorful logo

Vendorful

vendorful.com

Vetcove logo

Vetcove

shop.vetcove.com

GroupUps logo

GroupUps

groupups.com

Vendor Registry logo

Vendor Registry

vendorregistry.com

Procol logo

Procol

procol.io

Vetd logo

Vetd

CapExpert logo

CapExpert

capexpert.io

1Konnection logo

1Konnection

1konnection.com

Supply Clinic logo

Supply Clinic

supplyclinic.com

RxVantage logo

RxVantage

rxvantage.com

Grapevine - Quick Facts

Who are Grapevine's competitors?

Companies similar to Grapevine include InvoCure, DocShop Pro, Ravacan and Stimulus.

When was Grapevine founded?

Grapevine was founded in 2022.

Where is Grapevine's headquarters located?

Grapevine's headquarters is located in New York City, NY, US.

When was Grapevine's last funding round?

Grapevine's most recent funding round was for $2M (USD) in April 2022.

How much has Grapevine raised to-date?

As of Apr 1, 2022, Grapevine has raised a total of $2M (USD).

How many employees does Grapevine have?

Grapevine has 30 employees as of Feb 4, 2024.

Grapevine - Classification

Ownership
  • Venture Capital
Technology
  • Analytics
  • Automation
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
Main Product
  • Medical Supplies
Tags
  • Healthtech
  • SaaS
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software